Home›Compare›Josie vs Paloma Health

Josie vs Paloma Health: Which Is Better?

Head-to-head comparison of Josie and Paloma Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Paloma Health scores higher overall in our independent evaluation (57.7/100 vs 57.6/100), leading on trust & safety, reputation. Josie comes out ahead on value, experience, product range.

58
Josie
Fair

Small menopause-focused telehealth brand selling compounded and branded GLP-1s, microdose GLP-1 maintenance plans and estradiol/progesterone HRT at flat published prices.

Visit Josie

A niche telehealth brand built specifically around hypothyroidism and Hashimoto's care, pairing at-home lab testing with endocrinology-informed treatment.

Visit Paloma Health

Score Breakdown

DimensionJosiePaloma Health
Overall Score57.6/10057.7/100 ✓
Trust & Safety30%50/10058/100 ✓
Value25%70/100 ✓62/100
Experience20%58/100 ✓55/100
Product Range15%60/100 ✓55/100
Reputation10%45/10055/100 ✓

At a Glance

Founded—2018
Headquarters—New York, NY
Publicly tradedNoNo
Treatment categories32
Treatments listed73
Starting price$90/mo$20/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryJosiePaloma Health
Hormone Therapy$90–$100
Estradiol Patch or Cream (HRT)
$20
Thyroid Care Membership

Josie

+Flat pricing at any dose, published before intake: compounded semaglutide $249/mo ($194/mo prepaid annually), tirzepatide $349/mo ($233/mo annually)
+Offers injectable, oral ODT and microdose ($189/mo) GLP-1 formats alongside HRT in one women's-midlife intake
+Names its lead clinician (Dr. Ana Lisa Carr, MD, board-certified in family medicine) and says it serves all 50 states
−FDA warning letter (Feb 20, 2026) for misbranded compounded semaglutide/tirzepatide marketing
−White-label setup: Josie is a trade name of One Eleven Nutrition LLC on the CareValidate platform, and its terms say it doesn't control provider decisions
−An $80 consultation fee applies if a provider approves a plan and the patient declines medication, and filled orders are non-refundable
Read the full Josie review →

Paloma Health

+Narrow clinical focus on hypothyroidism/Hashimoto's with endocrinologist-informed care teams and integrated at-home lab testing, nutritionist visits, and medication management in one program.
+Transparent flat membership pricing ($20/mo billed $240/yr) that bundles two test kits and two visits per year.
+One of the only brands to specialize specifically in DTC thyroid care rather than treating it as one line item among many.
−Trustpilot rating is weak (2.6/5, though based on a very small sample of 4 reviews) with recurring complaints of care that didn't match advertised 'integrative'/'holistic' positioning.
−At least one reported case of a patient with clearly abnormal labs (TSH of 58) alleging the prescribing clinician disregarded their reported symptoms before prescribing a medication that caused adverse reactions — a serious quality-of-care concern for a specialty-clinical brand.
−Reviewers report membership fees and per-visit charges stacking in ways that felt like hidden costs.
Read the full Paloma Health review →

Josie vs Paloma Health — FAQ

Is Josie better than Paloma Health?

▾

Paloma Health scores higher overall in our independent evaluation (57.7/100 vs 57.6/100), leading on trust & safety, reputation. Josie comes out ahead on value, experience, product range.

Is Josie or Paloma Health cheaper?

▾

Paloma Health has the lower starting price (from $20/mo vs $90/mo for Josie). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Josie and Paloma Health both offer?

▾

Both platforms treat Hormone Therapy. Josie covers 3 treatment categories total and Paloma Health covers 2.

Still deciding?